These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 363616)
21. Serotyping and transferability of drug resistance in clinical isolates of E. coli. Husain RA; Wadher BJ; Daginawala HF; Deshmukh SR; Nagoba BS Indian J Pathol Microbiol; 1995 Oct; 38(4):355-7. PubMed ID: 9726143 [TBL] [Abstract][Full Text] [Related]
22. [Antibiotic susceptibility of E. coli strains isolated from urinary tract infections and the role of metabolically deficient strains in these infections]. Söyletir G; Günalp A Mikrobiyol Bul; 1985 Oct; 19(4):210-7. PubMed ID: 3913849 [TBL] [Abstract][Full Text] [Related]
23. R factors and colicins in Escherichia coli strains causing infections of the urinary apparatus. Chaloupecký V; Cahlíková O; Horák V; Láznicková K Zentralbl Bakteriol Orig A; 1974 Dec; 229(4):461-5. PubMed ID: 4155897 [No Abstract] [Full Text] [Related]
24. Prevalence of extended spectrum beta-lactamases producing clinical isolates from patients of urinary tract infection in a tertiary care hospital in Delhi. Malhotra VL; Khandpur N; Dass A; Mehta G J Commun Dis; 2008 Dec; 40(4):269-72. PubMed ID: 19579719 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of R factor carrying multiple drug resistant E. coli strains from cases of diarrhoea in children, U. T. I. and other clinical conditions. Aggarwal RK; Savena SN; Mago ML; Ahuja S Indian J Med Sci; 1984 Sep; 38(9):169-76. PubMed ID: 6392090 [No Abstract] [Full Text] [Related]
26. Antibiotic resistance, haemagglutination type & haemolysin production in relation to serogroups of uropathogenic Escherichia coli. Fule RP; Menon S; Saoji AM Indian J Med Res; 1990 Jul; 91():270-2. PubMed ID: 2228056 [TBL] [Abstract][Full Text] [Related]
27. [Frequency and antibiotic susceptibility of bacteria responsible for urinary infections in private practice from 1986 to 1990. Results of 5398 samples]. de Moüy D Pathol Biol (Paris); 1991 May; 39(5):495-9. PubMed ID: 1881681 [TBL] [Abstract][Full Text] [Related]
28. Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada--results of the CANWARD 2007-2009 study. Lagacé-Wiens PR; Simner PJ; Forward KR; Tailor F; Adam HJ; Decorby M; Karlowsky J; Hoban DJ; Zhanel GG; Diagn Microbiol Infect Dis; 2011 Mar; 69(3):314-9. PubMed ID: 21353959 [TBL] [Abstract][Full Text] [Related]
29. Rise in ciprofloxacin resistance in Escherichia coli from urinary tract infections from 1999-2004. Barisić Z; Borzić E; Kraljević KS; Carev M; Zoranić V; Kaliterna V Int J Antimicrob Agents; 2005 Jun; 25(6):550-1. PubMed ID: 15878822 [No Abstract] [Full Text] [Related]
30. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. Arslan H; Azap OK; Ergönül O; Timurkaynak F; J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685 [TBL] [Abstract][Full Text] [Related]
31. Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting. Kronenberg A; Koenig S; Droz S; Mühlemann K Clin Microbiol Infect; 2011 Dec; 17(12):1845-51. PubMed ID: 21880098 [TBL] [Abstract][Full Text] [Related]
32. The diagnostic and epidemiologic significance of nephropathogenic Escherichia coli serotypes. Borowski J; Dzierzanowska D; Zaremba M Arch Immunol Ther Exp (Warsz); 1970; 18(3):32-45. PubMed ID: 4923031 [No Abstract] [Full Text] [Related]
33. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition. Smith SP; Manges AR; Riley LW Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040 [TBL] [Abstract][Full Text] [Related]
34. Antibiotic resistance and small R plasmids among Escherichia coli isolates from outpatient urinary tract infections in northern Norway. Vorland LH; Carlson K; Aalen O Antimicrob Agents Chemother; 1985 Jan; 27(1):107-13. PubMed ID: 3885842 [TBL] [Abstract][Full Text] [Related]
35. Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli. Oteo J; Bautista V; Lara N; Cuevas O; Arroyo M; Fernández S; Lázaro E; de Abajo FJ; Campos J; J Antimicrob Chemother; 2010 Nov; 65(11):2459-63. PubMed ID: 20851815 [TBL] [Abstract][Full Text] [Related]
36. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. Yumuk Z; Afacan G; Nicolas-Chanoine MH; Sotto A; Lavigne JP J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527 [TBL] [Abstract][Full Text] [Related]
37. Anti-microbial resistance stratified by risk factor among Escherichia coli strains isolated from the urinary tract at a rural clinic in Central India. Chatterjee B; Kulathinal S; Bhargava A; Jain Y; Kataria R Indian J Med Microbiol; 2009; 27(4):329-34. PubMed ID: 19736402 [TBL] [Abstract][Full Text] [Related]
38. Increasing incidence of quinolone-resistant E. coli from urinary cultures in Ankara-Pursaklar region. Tekin O; Catal F; Ibýk B; Açýkgöz ZC Int J Antimicrob Agents; 2004 Apr; 23(4):416-7. PubMed ID: 15081097 [No Abstract] [Full Text] [Related]
39. Virulence factors and O groups of Escherichia coli strains isolated from cultures of blood specimens from urosepsis and non-urosepsis patients. Blanco M; Blanco JE; Alonso MP; Blanco J Microbiologia; 1994 Sep; 10(3):249-56. PubMed ID: 7532950 [TBL] [Abstract][Full Text] [Related]